Full Text View
Tabular View
No Study Results Posted
Related Studies
Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy (EPOHeart)
This study has been completed.
Study NCT00568542   Information provided by Charite University, Berlin, Germany
First Received: December 5, 2007   Last Updated: August 3, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ischemic Cardiomyopathy
Additional conditions recognized in this trial
Cardiomyopathies
Ischemia
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Pathologic Processes
Interventions listed in this trial
erythropoetin beta
placebo
Additional drug interventions recognized in this trial
Epoetin Alfa
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Charite University, Berlin, Germany


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services